OVARIAN CANCER and US

An ovarian cancer blog which includes quality resource materials: education, research, social networking, genetics and (some) healthcare politics.

“Not everything that can be counted counts and not everything that counts can be counted.”
Albert Einstein

Special items: Ovarian Cancer and Us blog best viewed in Firefox

▼
Showing posts with label A4. Show all posts
Showing posts with label A4. Show all posts
Saturday, February 05, 2011

abstract: Phase II trial of combretastatin A4 phosphate, carboplatin, and paclitaxel in patients with platinum-resistant ovarian cancer

›
Note: searching blog for A4 will provide further research specific to  clear cell/A4 CONCLUSIONS: The addition of CA4P to paclitaxel and...
Wednesday, August 04, 2010

Targeting annexin A4 to counteract chemoresistance in clear cell carcinoma of the ovary

›
Take home message: Annexin A4 enhances cancer cell chemoresistance and is overexpressed in tumors of patients with ovarian CCC. Targeting o...
Tuesday, April 13, 2010

A Phase Ib trial of CA4P (combretastatin A-4 phosphate), carboplatin, and paclitaxel in patients with advanced cancer

›
Conclusion: The combination of CA4P with carboplatin and paclitaxel was well tolerated in the majority of patients with adequate premedica...
›
Home
View web version

Sandi Pniauskas Ovarian Cancer and Us

OvarianCancerandUs
View my complete profile
Powered by Blogger.